Some Diabetes Drugs May Lower Cancer Risk, Cleveland Clinic Study

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

A recent study led by researchers from the Cleveland Clinic shows that certain types of diabetes drugs can help to decrease the risk of cancer in female patients with type 2 diabetes by up to 32 percent. Lead study author Sangeeta Kashyan, M.D., an endocrinologist and associate professor of medicine at Cleveland Clinic's Endocrinology & Metabolism Institute, examined two groups of drugs that are typically used to treat the disease: Insulin sensitizers and insulin secretagoues.

Hey, check out all the research scientist jobs. Post your resume today!

Back to news